Nature 2014[Oct]; 514 (7520): 41-3 PMID25171470show ga
A blend of three monoclonal antibodies has completely protected monkeys against a lethal dose of Ebola virus. Unlike other post-infection therapies, the treatment works even at advanced stages of the disease.